
Travere Therapeutics (TVTX) Earnings Dates & Reports
Travere Therapeutics (TVTX) Most Recent Earnings
Report DateMay 1, 2025
Period EndingQ1 2025
Est. EPS-$0.39
Actual EPS-$0.19
EarningsBeat
Travere Therapeutics (TVTX) Earnings
View the latest Travere Therapeutics (TVTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Travere Therapeutics (TVTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Travere Therapeutics (TVTX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Travere Therapeutics (TVTX) Latest Earnings
The value each TVTX share was expected to gain vs. the value each share gained.
Travere Therapeutics (TVTX) reported its most recent earnings on May 1, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.19. This exceeded analysts' expectations of -$0.39 by 51.28%, marking a Beat.
For comparison, Travere Therapeutics reported EPS of -$1.51 in the same quarter last year.
The company is expected to announce its next earnings report on 07/31/2025, with analysts projecting an EPS of $0.
Travere Therapeutics (TVTX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Jul 31, 2025 | – | Next earnings call Jul. 31, 2025 | ||
Q1 2025May 1, 2025 | -$0.39 | -$0.19 | -51.28% | |
Q4 2024Feb 20, 2025 | -$0.38 | -$0.47 | +23.68% | |
Q3 2024Oct 31, 2024 | -$0.68 | -$0.46 | -32.35% | |
Q2 2024Aug 1, 2024 | -$0.86 | -$0.65 | -24.42% | |
Travere Therapeutics (TVTX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Travere Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 1, 2025 | — | — | — |
Feb 20, 2025 | — | — | — |
Oct 31, 2024 | — | — | — |
Aug 1, 2024 | — | — | — |
Travere Therapeutics (TVTX) Earnings FAQs
Travere Therapeutics (TVTX) last reported earnings on May 1, 2025 for Q1 2025, posting an EPS of -$0.19, which Beat the estimate of -$0.39 by 51.28%.
For Q1 2025, Travere Therapeutics (TVTX) reported an EPS of -$0.19, exceeding analysts' estimate of -$0.39 by 51.28%.
For Q1 2025, Travere Therapeutics (TVTX) Beat expectations with an actual EPS of -$0.19 vs. an estimated EPS of -$0.39.
Following the last earnings report on May 1, 2025, Travere Therapeutics (TVTX)'s stock price moved — from — to —.
The next Travere Therapeutics (TVTX) earnings call is scheduled for Jul. 31, 2025, where executives will discuss financial results and outlook.